Sage Journals: Discover world-class research

Abstract

Previous case reports demonstrated the presence of Leber's hereditary optic neuropathy (LHON) associated mitochondrial (mt) DNA mutations in patients presenting with prominent optic neuritis (PON). By screening the mtDNA, we have excluded vie presence of these mutations in 22 patients with PON, indicating that the frequency of these mutations is less than 4.5% in our selected patient population. Reviewing the clinical data of these patients revealed that severe optic nerve atrophy developed in association with both the benign and the severely disabling form of Multiple Sclerosis (MS). This observation suggests that the prominent feature of ON in MS may be related to local factors or to a selective vulnerability of the optic nerve in some patients. However, it also may be a consequence of a deleterious process associated with inflammatory demyelination in the central nervous system (CNS) of another, genetically probably distinct subgroup of severely disabled patients.

Keywords

prominent optic neuritis mtDNA mutations multiple sclerosis

Get full access to this article

View all access options for this article.

References

1 Perkins GD , Rose FC . (1979) Optic neuritis and its differential diagnosis. Oxford, England: Oxford University Press, pp 192–200.

2 Beck RW et al. (1992) A randomized, controlled tiral of corticosteroids in the treatment of acute optic neuritis, N Engl J Med 326: 581–588.

3 Beck RW et al. (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329: 1764–1769.

4 Harding AE et al. (1992) Occurrence of multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 115: 979–989.

5 Flanigan KM , Johns DR . (1993) Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology 43: 2720–2722.

6 Kellar-Wood H , et al. (1994) Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 36: 109–112.

7 Olsen NK , et al. (1995) Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harboring the mitochondrial DNA 11778 mutation. Acta Neurol Scand 91: 326–329.

8 Riordan-Eva P et al. (1995) The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochrondrial DNA mutation. Brain 118: 319–337.

9 Nishimura M et al. (1995) No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 45: 1333–1334.

10.

10 Kalman B , Lublin F , Alder H . (1996) Characterization of the mitochondrial DNA in multiple sclerosis. J Neurol Sci 140: 75–89.

11.

11 Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231.

12.

12 Kalman B et al. (1996) The evolutionary relationship among Caucasian MS patients and controls. Multiple Sclerosis 1: 288–295.

13.

13 Kalman B , Lublin F , Alder H . (1995) Mitochondrial DNA mutations in multiple sclerosis. Multiple Sclerosis 1: 32–36.

Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis

Abstract

Keywords

Get full access to this article

References